Latest News

Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Vitamin D deficiency increases poor brain function after cardiac arrest by sevenfold

  • I have anxiety, why is my doctor prescribing an antipsychotic? New drug naming system unveiled

  • Women more likely to develop anxiety and depression after heart attack

  • Gene duplications associated with autism evolved recently in human history

  • Research reveals likelihood, onset of multiple sclerosis diagnosis among patients with inflammatory eye disease

  • Eating breakfast increases brain chemical involved in regulating food intake, cravings

  • Using feminist theory to understand male rape

  • YouTube as peer support for severe mental illness

  • Women driven by status, wealth rather than wanting babies, study suggests

  • Change your walking style, change your mood

  •